{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["benzimidazole 2-thione", "molecular docking", "o-phenylenediamine", "recombinant urease", "regioselectivity", "urease inhibition"]], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": ["IM"], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "35164122", "DateCompleted": {"Year": "2022", "Month": "02", "Day": "23"}, "DateRevised": {"Year": "2022", "Month": "02", "Day": "23"}, "Article": {"ArticleDate": [{"Year": "2022", "Month": "01", "Day": "27"}], "Language": ["eng"], "ELocationID": ["865", "10.3390/molecules27030865"], "Journal": {"ISSN": "1420-3049", "JournalIssue": {"Volume": "27", "Issue": "3", "PubDate": {"Year": "2022", "Month": "Jan", "Day": "27"}}, "Title": "Molecules (Basel, Switzerland)", "ISOAbbreviation": "Molecules"}, "ArticleTitle": "Expression, Purification, and Comparative Inhibition of <i>Helicobacter pylori</i> Urease by Regio-Selectively Alkylated Benzimidazole 2-Thione Derivatives.", "Abstract": {"AbstractText": ["The urease enzyme has been an important target for the discovery of effective pharmacological and agricultural products. Thirteen regio-selectively alkylated benzimidazole-2-thione derivatives have been designed to carry the essential features of urease inhibitors. The urease enzyme was isolated from <i>Helicobacter pylori</i> as a recombinant urease utilizing the His-tag method. The isolated enzyme was purified and characterized using chromatographic and FPLC techniques showing a maximal activity of 200 mg/mL. Additionally, the commercial <i>Jack bean</i> urease was purchased and included in this study for comparative and mechanistic investigations. The designed compounds were synthesized and screened for their inhibitory activity against the two ureases. Compound <b>2</b> inhibited <i>H. pylori</i> and <i>Jack bean</i> ureases with IC<sub>50</sub> values of 0.11; and 0.26 mM; respectively. While compound <b>5</b> showed IC<sub>50</sub> values of 0.01; and 0.29 mM; respectively. Compounds <b>2</b> and <b>5</b> were docked against <i>Helicobacter pylori</i> urease (PDB ID: 1E9Y; resolution: 3.00 \u00c5) and exhibited correct binding modes with free energy (\u0394G) values of -9.74 and -13.82 kcal mol<sup>-1</sup>; respectively. Further; the in silico ADMET and toxicity properties of <b>2</b> and <b>5</b> indicated their general safeties and likeness to be used as drugs. Finally, the compounds' safety was authenticated by an in vitro cytotoxicity assay against fibroblast cells."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Medicinal and Aromatic Plants and Traditional Medicine Research Institute, National Center for Research, Khartoum 11111, Sudan."}], "LastName": "Mohammed", "ForeName": "Salih Osman", "Initials": "SO"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Chemistry Department, Faculty of Science, Alexandria University, Alexandria 21568, Egypt."}], "LastName": "El Ashry", "ForeName": "Sayed H El", "Initials": "SHE"}, {"Identifier": ["0000-0001-8734-2588"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Medicinal and Aromatic Plants and Traditional Medicine Research Institute, National Center for Research, Khartoum 11111, Sudan."}, {"Identifier": [], "Affiliation": "Substance Abuse and Toxicology Research Center, Jazan University, Jazan 45142, Saudi Arabia."}], "LastName": "Khalid", "ForeName": "Asaad", "Initials": "A"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Chemistry Department, Faculty of Science, Alexandria University, Alexandria 21568, Egypt."}], "LastName": "Amer", "ForeName": "Mohamed R", "Initials": "MR"}, {"Identifier": ["0000-0001-8566-1980"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Pharmacognosy and Medicinal Plants Department, Faculty of Pharmacy (Boys), Al-Azhar University, Cairo 11884, Egypt."}, {"Identifier": [], "Affiliation": "Biopharmaceutical Products Research Department, Genetic Engineering and Biotechnology Research Institute, City of Scientific Research and Technological Applications (SRTA-City), Alexandria 21934, Egypt."}], "LastName": "Metwaly", "ForeName": "Ahmed M", "Initials": "AM"}, {"Identifier": ["0000-0002-6955-2263"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Pharmaceutical Medicinal Chemistry & Drug Design Department, Faculty of Pharmacy (Boys), Al-Azhar University, Cairo 11884, Egypt."}], "LastName": "Eissa", "ForeName": "Ibrahim H", "Initials": "IH"}, {"Identifier": ["0000-0002-2546-8035"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmaceutical Sciences, College of Pharmacy, AlMaarefa University, Ad Diriyah, Riyadh 13713, Saudi Arabia."}], "LastName": "Elkaeed", "ForeName": "Eslam B", "Initials": "EB"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Botany Department, Faculty of Science, Mansoura University, Mansoura 35516, Egypt."}], "LastName": "Elshobaky", "ForeName": "Ahmed", "Initials": "A"}, {"Identifier": ["0000-0003-4044-5103"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Plant Protection and Biomolecular Diagnosis Department, City of Scientific Research and Technological Applications, ARADI, Alexandria 21934, Egypt."}], "LastName": "Hafez", "ForeName": "Elsayed E", "Initials": "EE"}], "GrantList": [{"GrantID": "TUMA-2021-4", "Agency": "Research center at AlMaarefa University for funding this work under TUMA project", "Country": ""}], "PublicationTypeList": ["Comparative Study", "Journal Article"]}, "MedlineJournalInfo": {"Country": "Switzerland", "MedlineTA": "Molecules", "NlmUniqueID": "100964009", "ISSNLinking": "1420-3049"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Bacterial Proteins"}, {"RegistryNumber": "0", "NameOfSubstance": "Benzimidazoles"}, {"RegistryNumber": "0", "NameOfSubstance": "Enzyme Inhibitors"}, {"RegistryNumber": "EC 3.5.1.5", "NameOfSubstance": "Urease"}], "MeshHeadingList": [{"QualifierName": ["antagonists & inhibitors", "biosynthesis", "genetics", "isolation & purification"], "DescriptorName": "Bacterial Proteins"}, {"QualifierName": ["chemistry"], "DescriptorName": "Benzimidazoles"}, {"QualifierName": ["chemistry"], "DescriptorName": "Enzyme Inhibitors"}, {"QualifierName": ["enzymology", "genetics"], "DescriptorName": "Helicobacter pylori"}, {"QualifierName": [], "DescriptorName": "Molecular Docking Simulation"}, {"QualifierName": ["antagonists & inhibitors", "biosynthesis", "genetics", "isolation & purification"], "DescriptorName": "Urease"}], "CoiStatement": "The authors declare no conflict of interest."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Mazzei L., Musiani F., Ciurli S. The Biological Chemistry of Nickel. Royal Society of Chemistry; London, UK: 2017. Urease; pp. 60\u201397."}, {"Citation": "Polacco J.C., Holland M.A. Roles of urease in plant cells. Int. Rev. Cytol. 1993;145:65\u2013103."}, {"Citation": "Bury-Mon\u00e9 S., Skouloubris S., Labigne A., De Reuse H. The Helicobacter pylori UreI protein: Role in adaptation to acidity and identification of residues essential for its activity and for acid activation. Mol. Microbiol. 2001;42:1021\u20131034. doi: 10.1046/j.1365-2958.2001.02689.x.", "ArticleIdList": ["10.1046/j.1365-2958.2001.02689.x", "11737644"]}, {"Citation": "Sissons C., Yakub S. Suppression of urease levels in Streptococcus salivarius by cysteine, related compounds and by sulfide. Oral Microbiol. Immunol. 2000;15:317\u2013324. doi: 10.1034/j.1399-302x.2000.150509.x.", "ArticleIdList": ["10.1034/j.1399-302x.2000.150509.x", "11154424"]}, {"Citation": "Paczosa M.K., Mecsas J. Klebsiella pneumoniae: Going on the offense with a strong defense. Microbiol. Mol. Biol. Rev. 2016;80:629\u2013661. doi: 10.1128/MMBR.00078-15.", "ArticleIdList": ["10.1128/MMBR.00078-15", "PMC4981674", "27307579"]}, {"Citation": "Rosenstein I.J., Hamilton-Miller J., Musher D.M. Inhibitors of urease as chemotherapeutic agents. CRC Crit. Rev. Microbiol. 1984;11:1\u201312. doi: 10.3109/10408418409105901.", "ArticleIdList": ["10.3109/10408418409105901", "6373150"]}, {"Citation": "Mobley H., Island M.D., Hausinger R.P. Molecular biology of microbial ureases. Microbiol. Rev. 1995;59:451\u2013480. doi: 10.1128/mr.59.3.451-480.1995.", "ArticleIdList": ["10.1128/mr.59.3.451-480.1995", "PMC239369", "7565414"]}, {"Citation": "Arfan M., Ali M., Ahmad H., Anis I., Khan A., Choudhary M.I., Shah M.R. Urease inhibitors from Hypericum oblongifolium WALL. J. Enzym. Inhib. Med. Chem. 2010;25:296\u2013299. doi: 10.3109/14756360903179385.", "ArticleIdList": ["10.3109/14756360903179385", "20222765"]}, {"Citation": "Bremner J. Recent research on problems in the use of urea as a nitrogen fertilizer. Nitrogen Econ. Trop. Soils. 1995;42:321\u2013329."}, {"Citation": "Zaborska W., Krajewska B., Kot M., Karcz W. Quinone-induced inhibition of urease: Elucidation of its mechanisms by probing thiol groups of the enzyme. Bioorganic Chem. 2007;35:233\u2013242. doi: 10.1016/j.bioorg.2006.11.001.", "ArticleIdList": ["10.1016/j.bioorg.2006.11.001", "17169398"]}, {"Citation": "Salar U., Nizamani A., Arshad F., Khan K.M., Fakhri M.I., Perveen S., Ahmed N., Choudhary M.I. Bis-coumarins; non-cytotoxic selective urease inhibitors and antiglycation agents. Bioorganic Chem. 2019;91:103170. doi: 10.1016/j.bioorg.2019.103170.", "ArticleIdList": ["10.1016/j.bioorg.2019.103170", "31408830"]}, {"Citation": "Amtul Z., Rasheed M., Choudhary M.I., Rosanna S., Khan K.M. Kinetics of novel competitive inhibitors of urease enzymes by a focused library of oxadiazoles/thiadiazoles and triazoles. Biochem. Biophys. Res. Commun. 2004;319:1053\u20131063. doi: 10.1016/j.bbrc.2004.05.036.", "ArticleIdList": ["10.1016/j.bbrc.2004.05.036", "15184088"]}, {"Citation": "Channar P.A., Saeed A., Afzal S., Hussain D., Kalesse M., Shehzadi S.A., Iqbal J. Hydrazine clubbed 1,3-thiazoles as potent urease inhibitors: Design, synthesis and molecular docking studies. Mol. Divers. 2020;25:1\u201313. doi: 10.1007/s11030-020-10057-7.", "ArticleIdList": ["10.1007/s11030-020-10057-7", "32095975"]}, {"Citation": "Uesato S., Hashimoto Y., Nishino M., Nagaoka Y., Kuwajima H. N-substituted hydroxyureas as urease inhibitors. Chem. Pharm. Bull. 2002;50:1280\u20131282. doi: 10.1248/cpb.50.1280.", "ArticleIdList": ["10.1248/cpb.50.1280", "12237554"]}, {"Citation": "Fishbein W.N. Formamide: The minimum-structure substrate for urease. Biochim. Biophys. Acta (BBA)-Enzymol. 1977;484:433\u2013442. doi: 10.1016/0005-2744(77)90099-7.", "ArticleIdList": ["10.1016/0005-2744(77)90099-7", "20965"]}, {"Citation": "Benini S., Rypniewski W., Wilson K., Ciurli S., Mangani S. The complex of Bacillus pasteurii urease with \u03b2-mercaptoethanol from X-ray data at 1.65-\u00c5 resolution. JBIC J. Biol. Inorg. Chem. 1998;3:268\u2013273. doi: 10.1007/s007750050231.", "ArticleIdList": ["10.1007/s007750050231", "10766443"]}, {"Citation": "Ohta T., Shibata H., Kawamori T., Iimuro M., Sugimura T., Wakabayashi K. Marked reduction of Helicobacter pylori-induced gastritis by urease inhibitors, acetohydroxamic acid and flurofamide, in Mongolian gerbils. Biochem. Biophys. Res. Commun. 2001;285:728\u2013733. doi: 10.1006/bbrc.2001.5229.", "ArticleIdList": ["10.1006/bbrc.2001.5229", "11453654"]}, {"Citation": "Christianson C., Byrnes B., Carmona G. A comparison of the sulfur and oxygen analogs of phosphoric triamide urease inhibitors in reducing urea hydrolysis and ammonia volatilization. Fertil. Res. 1990;26:21\u201327. doi: 10.1007/BF01048741.", "ArticleIdList": ["10.1007/BF01048741"]}, {"Citation": "Benini S., Rypniewski W.R., Wilson K.S., Mangani S., Ciurli S. Molecular details of urease inhibition by boric acid: Insights into the catalytic mechanism. J. Am. Chem. Soc. 2004;126:3714\u20133715. doi: 10.1021/ja049618p.", "ArticleIdList": ["10.1021/ja049618p", "15038715"]}, {"Citation": "Salvador J.A., Figueiredo S.A., Pinto R.M., Silvestre S.M. Bismuth compounds in medicinal chemistry. Future Med. Chem. 2012;4:1495\u20131523. doi: 10.4155/fmc.12.95.", "ArticleIdList": ["10.4155/fmc.12.95", "22857536"]}, {"Citation": "Khan K.M., Rahim F., Khan A., Shabeer M., Hussain S., Rehman W., Taha M., Khan M., Perveen S., Choudhary M.I. Synthesis and structure\u2013activity relationship of thiobarbituric acid derivatives as potent inhibitors of urease. Bioorganic Med. Chem. 2014;22:4119\u20134123. doi: 10.1016/j.bmc.2014.05.057.", "ArticleIdList": ["10.1016/j.bmc.2014.05.057", "24986232"]}, {"Citation": "Wang X.J., Xi M.Y., Fu J.H., Zhang F.R., Cheng G.F., You Q.D. Synthesis, biological evaluation and SAR studies of benzimidazole derivatives as H1-antihistamine agents. Chin. Chem. Lett. 2012;23:707\u2013710. doi: 10.1016/j.cclet.2012.04.020.", "ArticleIdList": ["10.1016/j.cclet.2012.04.020"]}, {"Citation": "Palit R., Kumar R., Saraswat N., Wal A., Upadhyaya P. Benzimidazole: An Overview. Int. J. Res. Ayurveda Pharm. 2017;7:68\u201373. doi: 10.7897/2277-4343.076243.", "ArticleIdList": ["10.7897/2277-4343.076243"]}, {"Citation": "Sreena K., Ratheesh R., Rachana M., Poornima M., Shyni C. Synthesis and anthelmintic activity of benzimidazole derivatives. Hygei. 2009;1:21."}, {"Citation": "Preethi P.J., Karthikeyan E., Lohita M., Teja P.G., Subhash M., Shaheena P., Prashanth Y., Sai N.K. Benzimidazole: An important scaffold in drug discovery. Asian J. Pharm. Technol. 2015;5:138\u2013152. doi: 10.5958/2231-5713.2015.00021.5.", "ArticleIdList": ["10.5958/2231-5713.2015.00021.5"]}, {"Citation": "Tonelli M., Simone M., Tasso B., Novelli F., Boido V., Sparatore F., Paglietti G., Pricl S., Giliberti G., Blois S. Antiviral activity of benzimidazole derivatives. II. Antiviral activity of 2-phenylbenzimidazole derivatives. Bioorg. Med. Chem. 2010;18:2937\u20132953. doi: 10.1016/j.bmc.2010.02.037.", "ArticleIdList": ["10.1016/j.bmc.2010.02.037", "20359898"]}, {"Citation": "Bharadwaj S.S., Poojary B., Nandish S.K.M., Kengaiah J., Kirana M.P., Shankar M.K., Das A.J., Kulal A., Sannaningaiah D. Efficient synthesis and in silico studies of the benzimidazole hybrid scaffold with the quinolinyloxadiazole skeleton with potential \u03b1-glucosidase inhibitory, anticoagulant, and antiplatelet activities for type-II diabetes mellitus management and treating thrombotic disorders. ACS Omega. 2018;3:12562\u201312574.", "ArticleIdList": ["PMC6217529", "30411010"]}, {"Citation": "Gaba M., Singh S., Mohan C. Benzimidazole: An emerging scaffold for analgesic and anti-inflammatory agents. Eur. J. Med. Chem. 2014;76:494\u2013505. doi: 10.1016/j.ejmech.2014.01.030.", "ArticleIdList": ["10.1016/j.ejmech.2014.01.030", "24602792"]}, {"Citation": "Khalafi-Nezhad A., Rad M.S., Mohabatkar H., Asrari Z., Hemmateenejad B. Design, synthesis, antibacterial and QSAR studies of benzimidazole and imidazole chloroaryloxyalkyl derivatives. Bioorg. Med. Chem. 2005;13:1931\u20131938. doi: 10.1016/j.bmc.2005.01.014.", "ArticleIdList": ["10.1016/j.bmc.2005.01.014", "15727849"]}, {"Citation": "Soderlind K.-J., Gorodetsky B., Singh A.K., Bachur N.R., Miller G.G., Lown J.W. Bis-benzimidazole anticancer agents: Targeting human tumour helicases. Anti-Cancer Drug Des. 1999;14:19\u201336.", "ArticleIdList": ["10363025"]}, {"Citation": "Minkara M.S., Ucisik M.N., Weaver M.N., Merz K.M., Jr. Molecular dynamics study of Helicobacter pylori urease. J. Chem. Theory Comput. 2014;10:1852\u20131862. doi: 10.1021/ct5000023.", "ArticleIdList": ["10.1021/ct5000023", "PMC4020587", "24839409"]}, {"Citation": "Ha N.-C., Oh S.-T., Sung J.Y., Cha K.A., Lee M.H., Oh B.-H. Supramolecular assembly and acid resistance of Helicobacter pylori urease. Nat. Struct. Biol. 2001;8:505\u2013509. doi: 10.1038/88563.", "ArticleIdList": ["10.1038/88563", "11373617"]}, {"Citation": "Jabri E., Carr M.B., Hausinger R.P., Karplus P.A. The crystal structure of urease from Klebsiella aerogenes. Science. 1995;268:998\u20131004. doi: 10.1126/science.7754395.", "ArticleIdList": ["10.1126/science.7754395", "7754395"]}, {"Citation": "Arora R., Issar U., Kakkar R. In Silico study of the active site of Helicobacter pylori urease and its inhibition by hydroxamic acids. J. Mol. Graph. Model. 2018;83:64\u201373. doi: 10.1016/j.jmgm.2018.04.018.", "ArticleIdList": ["10.1016/j.jmgm.2018.04.018", "29775804"]}, {"Citation": "Sztanke K., Pasternak K., Sidor-W\u00f3jtowicz A., Truchli\u0144ska J., J\u00f3\u017awiak K. Synthesis of imidazoline and imidazo [2,1-c][1,2,4] triazole aryl derivatives containing the methylthio group as possible antibacterial agents. Bioorg. Med. Chem. 2006;14:3635\u20133642. doi: 10.1016/j.bmc.2006.01.019.", "ArticleIdList": ["10.1016/j.bmc.2006.01.019", "16455261"]}, {"Citation": "Andrzejewska M., Yepez-Mulia L., Tapia A., Cedillo-Rivera R., Laudy A.E., Staro\u015bciak B.J., Kazimierczuk Z. Synthesis, and antiprotozoal and antibacterial activities of S-substituted 4,6-dibromo-and 4,6-dichloro-2-mercaptobenzimidazoles. Eur. J. Pharm. Sci. 2004;21:323\u2013329. doi: 10.1016/j.ejps.2003.10.024.", "ArticleIdList": ["10.1016/j.ejps.2003.10.024", "14757505"]}, {"Citation": "Bickley J., Owen R., Fraser A., Pounder R. Evaluation of the polymerase chain reaction for detecting the urease C gene of Helicobacter pylori in gastric biopsy samples and dental plaque. J. Med. Microbiol. 1993;39:338\u2013344. doi: 10.1099/00222615-39-5-338.", "ArticleIdList": ["10.1099/00222615-39-5-338", "8246250"]}, {"Citation": "Labigne A., Cussac V., Courcoux P. Shuttle cloning and nucleotide sequences of Helicobacter pylori genes responsible for urease activity. J. Bacteriol. 1991;173:1920\u20131931. doi: 10.1128/jb.173.6.1920-1931.1991.", "ArticleIdList": ["10.1128/jb.173.6.1920-1931.1991", "PMC207722", "2001995"]}, {"Citation": "Basiri H., Mousavi S.L., Rasouli I., Basiri M., Yadgarinia D. Elicitation of IgY in chicken egg yolk by recombinant fragments of UreC and its efficacy against Helicobacter pylori. Iran. J. Clin. Infect. Dis. 2010;2:89\u201395."}, {"Citation": "El-Hefnawy M.E., Sakran M., Ismail A.I., Aboelfetoh E.F. Extraction, purification, kinetic and thermodynamic properties of urease from germinating Pisum Sativum L. seeds. BMC Biochem. 2014;15:15. doi: 10.1186/1471-2091-15-15.", "ArticleIdList": ["10.1186/1471-2091-15-15", "PMC4121304", "25065975"]}, {"Citation": "Tekiner P., Per\u00e7in I., Erg\u00fcn B., Yavuz H., Aks\u00f6z E. Purification of urease from jack bean (Canavalia ensiformis) with copper (II) chelated poly (hydroxyethyl methacrylate-N-methacryloyl-(l)-histidine methyl ester) cryogels. J. Mol. Recognit. 2012;25:549\u2013554. doi: 10.1002/jmr.2204.", "ArticleIdList": ["10.1002/jmr.2204", "23108614"]}, {"Citation": "Ardekani L.S., Gargari S.L.M., Rasooli I., Bazl M.R., Mohammadi M., Ebrahimizadeh W., Bakherad H., Zare H. A novel nanobody against urease activity of Helicobacter pylori. Int. J. Infect. Dis. 2013;17:e723\u2013e728. doi: 10.1016/j.ijid.2013.02.015.", "ArticleIdList": ["10.1016/j.ijid.2013.02.015", "23561799"]}, {"Citation": "Xia X., Maliski E.G., Gallant P., Rogers D. Classification of kinase inhibitors using a Bayesian model. J. Med. Chem. 2004;47:4463\u20134470. doi: 10.1021/jm0303195.", "ArticleIdList": ["10.1021/jm0303195", "15317458"]}, {"Citation": "BIOVIA. QSAR, ADMET and Predictive Toxicology.  [(accessed on 8 November 2021)].  Available online:  https://www.3dsbiovia.com/products/collaborative-science/biovia-discovery-studio/qsar-admet-and-predictive-toxicology.html."}, {"Citation": "Maniatis T. Molecular cloning. Decontam. Dilute Solut. Ethidium Bromide. 1989"}, {"Citation": "Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 1976;72:248\u2013254. doi: 10.1016/0003-2697(76)90527-3.", "ArticleIdList": ["10.1016/0003-2697(76)90527-3", "942051"]}, {"Citation": "Weatherburn M. Phenol-hypochlorite reaction for determination of ammonia. Anal. Chem. 1967;39:971\u2013974. doi: 10.1021/ac60252a045.", "ArticleIdList": ["10.1021/ac60252a045"]}, {"Citation": "Mohammed S.O., Elshahaby O., Hafez E.E., Mohammed A., Ahmed E. Characterization and purification of urease enzyme from new proteus mirabilis strain. J. Adv. Sci. Res. 2014;5:08\u201311."}, {"Citation": "Eissa I.H., Metwaly A.M., Belal A., Mehany A.B., Ayyad R.R., El-Adl K., Mahdy H.A., Taghour M.S., El-Gamal K.M., El-Sawah M.E. Discovery and antiproliferative evaluation of new quinoxalines as potential DNA intercalators and topoisomerase II inhibitors. Arch. Pharm. 2019;352:1900123. doi: 10.1002/ardp.201900123.", "ArticleIdList": ["10.1002/ardp.201900123", "31463953"]}, {"Citation": "Ibrahim M.K., Eissa I.H., Abdallah A.E., Metwaly A.M., Radwan M., ElSohly M. Design, synthesis, molecular modeling and anti-hyperglycemic evaluation of novel quinoxaline derivatives as potential PPAR\u03b3 and SUR agonists. Bioorg. Med. Chem. 2017;25:1496\u20131513. doi: 10.1016/j.bmc.2017.01.015.", "ArticleIdList": ["10.1016/j.bmc.2017.01.015", "28117121"]}, {"Citation": "Eissa I.H., El-Helby A.-G.A., Mahdy H.A., Khalifa M.M., Elnagar H.A., Mehany A.B., Metwaly A.M., Elhendawy M.A., Radwan M.M., ElSohly M.A. Discovery of new quinazolin-4 (3H)-ones as VEGFR-2 inhibitors: Design, synthesis, and anti-proliferative evaluation. Bioorg. Chem. 2020;105:104380. doi: 10.1016/j.bioorg.2020.104380.", "ArticleIdList": ["10.1016/j.bioorg.2020.104380", "33128967"]}, {"Citation": "El-Helby A.-G.A., Sakr H., Ayyad R.R., Mahdy H.A., Khalifa M.M., Belal A., Rashed M., El-Sharkawy A., Metwaly A.M., Elhendawy M.A. Design, synthesis, molecular modeling, in vivo studies and anticancer activity evaluation of new phthalazine derivatives as potential DNA intercalators and topoisomerase II inhibitors. Bioorg. Chem. 2020;103:104233. doi: 10.1016/j.bioorg.2020.104233.", "ArticleIdList": ["10.1016/j.bioorg.2020.104233", "32882440"]}, {"Citation": "El-Adl K., El-Helby A.-G.A., Ayyad R.R., Mahdy H.A., Khalifa M.M., Elnagar H.A., Mehany A.B., Metwaly A.M., Elhendawy M.A., Radwan M.M. Design, synthesis, and anti-proliferative evaluation of new quinazolin-4 (3H)-ones as potential VEGFR-2 inhibitors. Bioorg. Med. Chem. 2021;29:115872. doi: 10.1016/j.bmc.2020.115872.", "ArticleIdList": ["10.1016/j.bmc.2020.115872", "33214036"]}, {"Citation": "Eissa I.H., Ibrahim M.K., Metwaly A.M., Belal A., Mehany A.B., Abdelhady A.A., Elhendawy M.A., Radwan M.M., ElSohly M.A., Mahdy H.A. Design, molecular docking, in vitro, and in vivo studies of new quinazolin-4 (3H)-ones as VEGFR-2 inhibitors with potential activity against hepatocellular carcinoma. Bioorg. Chem. 2021;107:104532. doi: 10.1016/j.bioorg.2020.104532.", "ArticleIdList": ["10.1016/j.bioorg.2020.104532", "33334586"]}, {"Citation": "Zhanzhaxina A., Suleimen Y., Metwaly A.M., Eissa I.H., Elkaeed E.B., Suleimen R., Ishmuratova M., Akatan K., Luyten W. In vitro and in silico cytotoxic and antibacterial activities of a diterpene from cousinia alata schrenk. J. Chem. 2021;2021:5542455. doi: 10.1155/2021/5542455.", "ArticleIdList": ["10.1155/2021/5542455"]}, {"Citation": "Alesawy M.S., Abdallah A.E., Taghour M.S., Elkaeed E.B., H Eissa I., Metwaly A.M. In Silico Studies of Some Isoflavonoids as Potential Candidates against COVID-19 Targeting Human ACE2 (hACE2) and Viral Main Protease (Mpro) Molecules. 2021;26:2806. doi: 10.3390/molecules26092806.", "ArticleIdList": ["10.3390/molecules26092806", "PMC8126168", "34068579"]}, {"Citation": "Parmar D.R., Soni J.Y., Guduru R., Rayani R.H., Kusurkar R.V., Vala A.G., Talukdar S.N., Eissa I.H., Metwaly A.M., Khalil A. Discovery of new anticancer thiourea-azetidine hybrids: Design, synthesis, in vitro antiproliferative, SAR, in silico molecular docking against VEGFR-2, ADMET, toxicity, and DFT studies. Bioorg. Chem. 2021;115:105206. doi: 10.1016/j.bioorg.2021.105206.", "ArticleIdList": ["10.1016/j.bioorg.2021.105206", "34339975"]}, {"Citation": "Yousef R.G., Sakr H.M., Eissa I.H., Mehany A.B., Metwaly A.M., Elhendawy M.A., Radwan M.M., ElSohly M.A., Abulkhair H.S., El-Adl K. New quinoxaline-2 (1 H)-ones as potential VEGFR-2 inhibitors: Design, synthesis, molecular docking, ADMET profile and anti-proliferative evaluations. New J. Chem. 2021;45:16949\u201316964. doi: 10.1039/D1NJ02509K.", "ArticleIdList": ["10.1039/D1NJ02509K", "34175720"]}, {"Citation": "El-Demerdash A., Metwaly A.M., Hassan A., El-Aziz A., Mohamed T., Elkaeed E.B., Eissa I.H., Arafa R.K., Stockand J.D. Comprehensive virtual screening of the antiviral potentialities of marine polycyclic guanidine alkaloids against SARS-CoV-2 (COVID-19) Biomolecules. 2021;11:460. doi: 10.3390/biom11030460.", "ArticleIdList": ["10.3390/biom11030460", "PMC8003478", "33808721"]}, {"Citation": "El-Adl K., Sakr H.M., Yousef R.G., Mehany A.B., Metwaly A.M., Elhendawy M.A., Radwan M.M., ElSohly M.A., Abulkhair H.S., Eissa I.H. Discovery of new quinoxaline-2 (1H)-one-based anticancer agents targeting VEGFR-2 as inhibitors: Design, synthesis, and anti-proliferative evaluation. Bioorg. Chem. 2021;114:105105. doi: 10.1016/j.bioorg.2021.105105.", "ArticleIdList": ["10.1016/j.bioorg.2021.105105", "34175720"]}, {"Citation": "Jalmakhanbetova R., Elkaeed E.B., Eissa I.H., Metwaly A.M., Suleimen Y.M. Synthesis and Molecular Docking of Some Grossgemin Amino Derivatives as Tubulin Inhibitors Targeting Colchicine Binding Site. J. Chem. 2021;2021:5586515. doi: 10.1155/2021/5586515.", "ArticleIdList": ["10.1155/2021/5586515"]}, {"Citation": "Borenfreund E., Puerner J.A. Toxicity determined in vitro by morphological alterations and neutral red absorption. Toxicol. Lett. 1985;24:119\u2013124. doi: 10.1016/0378-4274(85)90046-3.", "ArticleIdList": ["10.1016/0378-4274(85)90046-3", "3983963"]}], "ReferenceList": []}], "History": [{"Year": "2021", "Month": "12", "Day": "8"}, {"Year": "2022", "Month": "1", "Day": "22"}, {"Year": "2022", "Month": "1", "Day": "24"}, {"Year": "2022", "Month": "2", "Day": "15", "Hour": "1", "Minute": "19"}, {"Year": "2022", "Month": "2", "Day": "16", "Hour": "6", "Minute": "0"}, {"Year": "2022", "Month": "2", "Day": "24", "Hour": "6", "Minute": "0"}, {"Year": "2022", "Month": "1", "Day": "27"}], "PublicationStatus": "epublish", "ArticleIdList": ["35164122", "PMC8838460", "10.3390/molecules27030865", "molecules27030865"]}}], "PubmedBookArticle": []}